[HTML][HTML] Sex and gender differences in hepatitis C virus risk, prevention, and cascade of care in people who inject drugs: systematic review and meta-analysis
A Levinsson, C Zolopa, F Vakili, S Udhesister… - …, 2024 - thelancet.com
Background People who inject drugs (PWID) are a priority population in HCV elimination
programming. Overcoming sex and gender disparities in HCV risk, prevention, and the …
programming. Overcoming sex and gender disparities in HCV risk, prevention, and the …
Screening for viral hepatitis carriage
J Tang, H Zhao, YH Zhou - Best Practice & Research Clinical Obstetrics & …, 2024 - Elsevier
Viral hepatitis during pregnancy is common globally. In this review, we focus on the
antenatal screen for hepatitis A, B, C and E, the prevention of mother-to-child transmission …
antenatal screen for hepatitis A, B, C and E, the prevention of mother-to-child transmission …
[HTML][HTML] Applying a stigma and time framework to facilitate equitable access to hepatitis C care among women who inject drugs: The ETHOS Engage Study
Background Women who inject drugs are significantly less likely to initiate hepatitis C virus
(HCV) treatment than men. Concerted efforts are needed to minimise gender-based …
(HCV) treatment than men. Concerted efforts are needed to minimise gender-based …
[HTML][HTML] Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs: The ETHOS engage study
Background Evaluating gender-specific trends in hepatitis C virus (HCV) treatment uptake
among men and women who inject drugs is crucial for ensuring equitable progress towards …
among men and women who inject drugs is crucial for ensuring equitable progress towards …